Literature DB >> 16435911

Ionizing radiation enhances the expression of the nonsteroidal anti-inflammatory drug-activated gene (NAG1) by increasing the expression of TP53 in human colon cancer cells.

Ryuji Okazaki1, Yuseok Moon, Toshiyuki Norimura, Thomas Eling.   

Abstract

The induction of apoptosis in cells of human colon cancer cell lines after gamma irradiation was investigated to determine whether apoptosis was mediated by TP53 and the subsequent expression of its downstream target, the NSAID-activated gene (NAG1). HCT116 (TP53(+/+)), HCT15 (TP53 mutant) and TP53 null HCT116 (TP53(-/-)) cells were irradiated with gamma rays, and apoptosis was measured at various times after irradiation. In HCT116 TP53(+/+) cells, apoptosis was increased after irradiation; the increase was dependent on the time after treatment and the dose of gamma rays. However, in HCT15 TP53 mutant cells and HCT116 TP53(-/-) cells, there were no remarkable changes in apoptosis. The expression of TP53 protein in HCT116 cells was increased after irradiation and was followed by an increase in the expression of NAG1 protein. In contrast, the expression of NAG1 protein in TP53 mutant cells and TP53(-/-) cells was not increased by the radiation treatment, suggesting that NAG1 was required for apoptosis. The expression of NAG1 increased apoptosis in HCT116 cells, but radiation treatment did not further increase apoptosis. The transfection of a NAG1 siRNA into HCT116 cells suppressed radiation-induced apoptosis and inhibited the induction of NAG1 protein without altering the expression of TP53. a NAG1 luciferase promoter construct that included both of the TP53 binding sites, was activated by radiation in dose-dependent manner, while the promoters lacking one or both of the TP53 binding sites in the NAG1 promoter activity either was less responsive or did not respond. The findings reported here indicate that gamma radiation activates the TP53 tumor suppressor, which then increases the expression of NAG1. NAG1 mediates the induction of apoptosis in human colorectal cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16435911     DOI: 10.1667/rr3492.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

Review 1.  Key mechanisms involved in ionizing radiation-induced systemic effects. A current review.

Authors:  Ifigeneia V Mavragani; Danae A Laskaratou; Benjamin Frey; Serge M Candéias; Udo S Gaipl; Katalin Lumniczky; Alexandros G Georgakilas
Journal:  Toxicol Res (Camb)       Date:  2015-08-11       Impact factor: 3.524

2.  Two in-and-out modulation strategies for endoplasmic reticulum stress-linked gene expression of pro-apoptotic macrophage-inhibitory cytokine 1.

Authors:  Seong-Hwan Park; Hye Jin Choi; Hyun Yang; Kee Hun Do; Juil Kim; Hyun-Hong Kim; Heejeong Lee; Chang Gyu Oh; Dong Won Lee; Yuseok Moon
Journal:  J Biol Chem       Date:  2012-04-17       Impact factor: 5.157

3.  Comparative Analysis of Whole-Genome Gene Expression Changes in Cultured Human Embryonic Stem Cells in Response to Low, Clinical Diagnostic Relevant, and High Doses of Ionizing Radiation Exposure.

Authors:  Mykyta Sokolov; Van Nguyen; Ronald Neumann
Journal:  Int J Mol Sci       Date:  2015-06-30       Impact factor: 5.923

4.  Effects of low doses of ionizing radiation exposures on stress-responsive gene expression in human embryonic stem cells.

Authors:  Mykyta Sokolov; Ronald Neumann
Journal:  Int J Mol Sci       Date:  2014-01-06       Impact factor: 5.923

5.  Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity.

Authors:  Barbara Łasut-Szyszka; Beata Małachowska; Agnieszka Gdowicz-Kłosok; Małgorzata Krześniak; Magdalena Głowala-Kosińska; Artur Zajkowicz; Marek Rusin
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

6.  Analysis of gene expression in normal and cancer cells exposed to gamma-radiation.

Authors:  M Ahmad Chaudhry
Journal:  J Biomed Biotechnol       Date:  2008

7.  Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent.

Authors:  Pan Pantziarka; Vidula Sukhatme; Gauthier Bouche; Lydie Meheus; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2016-01-11

8.  Diclofenac N-Derivatives as Therapeutic Agents with Anti-Inflammatory and Anti-Cancer Effect.

Authors:  Alberto Galisteo; Fatin Jannus; Amalia García-García; Houssam Aheget; Sara Rojas; José A Lupiañez; Antonio Rodríguez-Diéguez; Fernando J Reyes-Zurita; José F Quílez Del Moral
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.